RMS 1.30% $2.27 ramelius resources limited

RMS Chart, page-626

  1. 91 Posts.
    lightbulb Created with Sketch. 10
    Everyone was surprised by the effectivity of the vacine tests, as it was not expected. Now if Pfizer goes into full production, wich there planning, then they will be able to vacinnate 5% of the world population by end of next year, not really enough. Now there are 12 other companies going into final testing of there vacinnes and if half of them are good then we could vaccinate 20% of world population, if there all good we could vaccinate maybe 35% by the end of next year if they all produce similar amount as Pfizer in that year. So herd imunity may kick in around end of 2022 if all goes well. By that time they may realise what sort of a mess were in.
    So things are not getting better in the near future, keep buying gold stocks and or bullion.
 
watchlist Created with Sketch. Add RMS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.